AU4306401A - Dna encoding a novel prost-ets polypeptide - Google Patents

Dna encoding a novel prost-ets polypeptide

Info

Publication number
AU4306401A
AU4306401A AU43064/01A AU4306401A AU4306401A AU 4306401 A AU4306401 A AU 4306401A AU 43064/01 A AU43064/01 A AU 43064/01A AU 4306401 A AU4306401 A AU 4306401A AU 4306401 A AU4306401 A AU 4306401A
Authority
AU
Australia
Prior art keywords
prost
ets
polypeptide
novel
dna encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43064/01A
Inventor
Richard Harkins
Richard J. Lin
May Luke
Felipe Monteclaro
Deborah Parkes
Gordon Parry
Renate Steinbrecher
Pamela Toy Van Heuit
Jian-Ai Xuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU4306401A publication Critical patent/AU4306401A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6843—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU43064/01A 1999-11-30 2000-11-29 Dna encoding a novel prost-ets polypeptide Abandoned AU4306401A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16818299P 1999-11-30 1999-11-30
US60168182 1999-11-30
US71815900A 2000-11-21 2000-11-21
US09718159 2000-11-21
PCT/US2000/042295 WO2001042472A2 (en) 1999-11-30 2000-11-29 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE

Publications (1)

Publication Number Publication Date
AU4306401A true AU4306401A (en) 2001-06-18

Family

ID=26863872

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43064/01A Abandoned AU4306401A (en) 1999-11-30 2000-11-29 Dna encoding a novel prost-ets polypeptide

Country Status (6)

Country Link
EP (1) EP1234037A2 (en)
JP (1) JP2003533177A (en)
AU (1) AU4306401A (en)
HK (1) HK1049352A1 (en)
NO (1) NO20022542L (en)
WO (1) WO2001042472A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7867731B2 (en) 1998-11-04 2011-01-11 Novartis Vaccines And Diagnostics, Inc. HX2004-6 polypeptide expressed in cancerous cells
WO2000070092A1 (en) 1999-05-14 2000-11-23 Chiron Corporation Expression of ets-domain proteins in cancer
CA2443123A1 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
TWI570662B (en) * 2016-04-27 2017-02-11 國立彰化師範大學 Gene synthesis teaching system and method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265565B1 (en) * 1998-04-03 2001-07-24 Incyte Genomics, Inc. Prostate associated Ets protein
US20010010934A1 (en) * 1998-07-31 2001-08-02 Towia Aron Libermann Prostate derived ets factor
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
WO2000070092A1 (en) * 1999-05-14 2000-11-23 Chiron Corporation Expression of ets-domain proteins in cancer

Also Published As

Publication number Publication date
NO20022542L (en) 2002-07-29
NO20022542D0 (en) 2002-05-29
WO2001042472A3 (en) 2002-05-10
JP2003533177A (en) 2003-11-11
WO2001042472A2 (en) 2001-06-14
EP1234037A2 (en) 2002-08-28
HK1049352A1 (en) 2003-05-09

Similar Documents

Publication Publication Date Title
AU1220001A (en) Novel proteins and polynucleotides encoding them
AU5372399A (en) Dna encoding a human inhibitor-of-apoptosis protein; hiap3
GB9923177D0 (en) Novel polypeptide
AU2001284418A1 (en) Novel polypeptide
AU5706000A (en) Useful polypeptide
AU2001257252A1 (en) Dna encoding a novel prost 03 polypeptide
AU4306401A (en) Dna encoding a novel prost-ets polypeptide
GB9923889D0 (en) Novel polypeptide
AU2691500A (en) Novel polypeptide
AU7753700A (en) Dna encoding prost 07 polypeptide
AU4778600A (en) Novel polypeptide
GB9924951D0 (en) Novel polypeptide
AU6181500A (en) Gene encoding novel tsp1-like protein
AU1453601A (en) Novel polypeptides and nucleic acids encoding same
AU5999099A (en) Dnas encoding novel polypeptides
AU2109200A (en) Polypeptide
AU1228201A (en) Umlr polypeptides
AU6712600A (en) Polypeptides
GB9923890D0 (en) Novel polypeptide
GB9923893D0 (en) Novel polypeptide
AU2002224056A1 (en) Novel polypeptide
AU6637700A (en) Tryptase-like polypeptide ztryp1
AU2002213787A1 (en) A novel lapemis hardwicki phosphatidase a2 and gene encoding said polypeptide
GB9925115D0 (en) Novel polypeptide
GB9924960D0 (en) Novel polypeptide

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase